Cargando…
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
BACKGROUND: Breast cancer is a common cancer among women in the world. However, its pathogenesis is still to be determined. The role and molecular mechanism of Nucleosome Assembly Protein 1 Like 1 (NAP1L1) in breast cancer have not been reported. Elucidation of molecular mechanism might provide a no...
Autores principales: | Liu, Shu, Zhang, Yewei, Cui, Shien, Song, Dajiang, Li, Bo, Chen, Qian, Yao, Guangyu, Gong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590370/ https://www.ncbi.nlm.nih.gov/pubmed/34774047 http://dx.doi.org/10.1186/s12935-021-02301-3 |
Ejemplares similares
-
Correction to: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
por: Liu, Shu, et al.
Publicado: (2022) -
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma
por: Zhang, Ye-wei, et al.
Publicado: (2021) -
NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5: NAP1L1 promotes colon cancer growth
por: Liang, Xuemin, et al.
Publicado: (2022) -
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019) -
UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
por: Zhou, Sitong, et al.
Publicado: (2021)